These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 36598390)
21. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Chao AN; Shields CL; Krema H; Shields JA Ophthalmology; 2001 Oct; 108(10):1877-83. PubMed ID: 11581065 [TBL] [Abstract][Full Text] [Related]
22. Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign Versus Malignant Counterparts. The 2016 James D. Allen Lecture. Shields CL; Alset AE; Boal NS; Casey MG; Knapp AN; Sugarman JA; Schoen MA; Gordon PS; Douglass AM; Sioufi K; Say EA; Shields JA Am J Ophthalmol; 2017 Jan; 173():106-133. PubMed ID: 27725148 [TBL] [Abstract][Full Text] [Related]
23. Conjunctival Melanoma: Features and Outcomes Based on the Fitzpatrick Skin Type in 540 Patients at a Single Ocular Oncology Center. Shields CL; Yaghy A; Dalvin LA; Vaidya S; Pacheco RR; Perez AL; Ramesh S; George K; Arias DE; Shiuey EJ; Lally SE; Shields JA Ophthalmic Plast Reconstr Surg; 2020; 36(5):490-496. PubMed ID: 32134771 [TBL] [Abstract][Full Text] [Related]
24. Conjunctival and uveal melanoma: Survival and risk factors following orbital exenteration. Baum SH; Westekemper H; Bechrakis NE; Mohr C Eur J Ophthalmol; 2022 Jan; 32(1):612-619. PubMed ID: 33573425 [TBL] [Abstract][Full Text] [Related]
25. Conjunctival melanoma in the Netherlands: a nationwide study. Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757 [TBL] [Abstract][Full Text] [Related]
26. Secondary orbital exenteration for conjunctival melanoma: A study of 25 cases. Lemaître S; Lévy-Gabriel C; Dendale R; Vincent-Salomon A; Lumbroso-Le Rouic L; Cassoux N; Couturaud B; Desjardins L J Fr Ophtalmol; 2021 Mar; 44(3):415-419. PubMed ID: 33573797 [TBL] [Abstract][Full Text] [Related]
27. Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients. Lally SE; Milman T; Orloff M; Dalvin LA; Eberhart CG; Heaphy CM; Rodriguez FJ; Lin CC; Dockery PW; Shields JA; Shields CL Ophthalmology; 2022 Jun; 129(6):679-693. PubMed ID: 35085662 [TBL] [Abstract][Full Text] [Related]
28. Malignant melanoma of the lacrimal drainage apparatus complicating conjunctival melanoma. Satchi K; McKelvie P; McNab AA Ophthalmic Plast Reconstr Surg; 2015; 31(3):207-10. PubMed ID: 25126770 [TBL] [Abstract][Full Text] [Related]
29. Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma. Yousef YA; Finger PT Arch Ophthalmol; 2012 May; 130(5):599-606. PubMed ID: 22652846 [TBL] [Abstract][Full Text] [Related]
30. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease. Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646 [TBL] [Abstract][Full Text] [Related]
31. American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes. Shields CL; Kaliki S; Al-Dahmash SA; Lally SE; Shields JA Ophthalmic Plast Reconstr Surg; 2012; 28(5):313-23. PubMed ID: 22965011 [TBL] [Abstract][Full Text] [Related]
32. Conjunctival melanoma: Risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center. Vaidya S; Dalvin LA; Yaghy A; Pacheco R; Shields JA; Lally SE; Shields CL Eur J Ophthalmol; 2021 Sep; 31(5):2675-2685. PubMed ID: 33176471 [TBL] [Abstract][Full Text] [Related]
33. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture. Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168 [TBL] [Abstract][Full Text] [Related]
34. Conjunctival melanoma: association of cyclooxygenase-2 tumor expression to prognosis. Pinto-Proença R; Santos M; Fonseca C; Fernandes J; Gaspar MF; Proença R Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):989-995. PubMed ID: 29297092 [TBL] [Abstract][Full Text] [Related]
35. [Pathology and prognostic factors of conjunctival melanoma]. Berta-Antalics AI; Kruse FE; Holbach L Ophthalmologe; 2015 Nov; 112(11):892, 894-8. PubMed ID: 26531292 [TBL] [Abstract][Full Text] [Related]
36. Orbital exenteration for conjunctival melanoma: comparison of long-term outcome between individualised and conventional techniques. Ma R; Ren H; Zhou X; Gan L; Xu B; Guo J; Qian J Eye (Lond); 2021 Dec; 35(12):3410-3418. PubMed ID: 33608640 [TBL] [Abstract][Full Text] [Related]
37. Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Shields CL; Markowitz JS; Belinsky I; Schwartzstein H; George NS; Lally SE; Mashayekhi A; Shields JA Ophthalmology; 2011 Feb; 118(2):389-95.e1-2. PubMed ID: 20723990 [TBL] [Abstract][Full Text] [Related]
38. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Esmaeli B; Wang X; Youssef A; Gershenwald JE Ophthalmology; 2001 Nov; 108(11):2101-5. PubMed ID: 11713086 [TBL] [Abstract][Full Text] [Related]
39. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Demirci H; McCormick SA; Finger PT Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099 [TBL] [Abstract][Full Text] [Related]